Fig. 2From: Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the diseaseActuarial probability of remaining survival at different stages of cirrhotic patients (compensated liver cirrhosis). There was a similar probability of survival between compensated patients who were prescribed with intravenous ceftriaxone and those without antibiotic prophylaxis (p = 0.830 by log-rank test)Back to article page